Viatris resolves case over use of woman's cancer cells to advance drug research
Source: SeekingAlpha
2026-03-12 12:20:25 ET
More on Viatris
- Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript
- Viatris Inc. 2025 Q4 - Results - Earnings Call Presentation
- Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation
- GoodRx to offer up to 85% discount on Viatris drugs
- Top 10 healthcare stocks with highest dividend yield amid volatile markets
Read the full article on Seeking Alpha
For further details see:
Viatris resolves case over use of woman’s cancer cells to advance drug research
Novartis AG
NASDAQ: NVS
NVS Trading
-0.26% G/L:
$150.47 Last:
852,043 Volume:
$151.84 Open:
NVS Latest News
February 24, 2026 04:52:00 pm
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
NVS Stock Data
$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel
